Philips Debuts Fully Integrated Suite of Enhanced Patient Monitoring Solutions in U.S. Market

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system consists of bedside, transport, mobile and central station monitoring technology backed by a new approach to consulting, training, service and customer support, including a full range of product support and expert services. The latest offering features the IntelliVue X3, a transport monitor with intuitive smart-phone-style operation released in 2017. By harmonizing monitoring system updates and improved service agreements, the solution is designed to help clinicians improve patient care, drive clinical performance and assist health systems in lowering costs.

When patients are admitted to the hospital, they are frequently transferred between departments, which can make it difficult for healthcare professionals to obtain complete data from monitoring systems that operate independently of one another. Incomplete data not only limits clinicians’ view into the patient’s condition, but can put a patient’s safety at risk. In a recent Philips-sponsored study, results revealed patient safety is still a top concern for physician and nurse leaders in the U.S. The results showed data is playing an increasingly important role in patient safety, with 74 percent of physician and nurse leaders saying they believe lack of patient data during in-hospital transport is a risk to patients.

"The healthcare industry is making strides to address clinician pain points, but issues such as lack of complete patient data and exhaustive alarm fatigue still remain," said Felix Baader, Business Leader, Monitoring & Analytics at Philips. "While challenges persist, there is an opportunity to improve and address the barriers that clinicians are currently facing with technology. We are aiming to provide clinicians with smarter alarms and seamless solutions to lower the chances of preventable adverse events, while helping them to improve patient care."

The IntelliVue X3 is a highly portable, dual-purpose monitor with intuitive smart-phone-style operation. With this monitor, there is no need for caregivers to change patient cables during transport or at bedside, allowing them to spend less time dealing with equipment and more time caring for the patient. With alarm fatigue a top concern for healthcare professionals, the Patient Monitoring solution also includes IntelliVue bedside monitors with Alarm Advisor, a tool that tracks how clinicians respond to alarms and alerts them when set thresholds may be too sensitive.

As a comprehensive system, the Patient Monitoring solution captures a steady stream of detailed patient data from monitors and medical devices, and feeds it securely to the hospital's EMR for virtually gap-free patient records from admission to discharge, even during transport. The integrated solution fits securely into health systems' existing IT environment, delivering vital signs, waveforms and alarms directly to caregivers. By incorporating these clinical decision support tools and advanced algorithms, caregivers have better visibility into a patient's changing condition. All Philips bedside, transport, and mobile monitors share the same look, feel, and interface for consistency and to reduce complexity, accelerate care, making it easier for clinicians to provide the best quality care throughout patients' transports around the hospital.

The Patient Monitoring solution is available in the U.S. The newest offering in the solution, IntelliVue X3, has recently received 510(k) clearance in the U.S.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...